Safety of an IV Formulation of Carbamazepine

An intravenous formulation of carbamazepine (CBZ) was administered to 113 (60 male; 53 female) persons with epilepsy aged 19 to 87 years. Subjects received 100 mg of study drug as replacement for 100 mg of their usual morning dose of CBZ. There were no significant changes in blood pressure or heart...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Conway, Jeannine M., White, James R., Birnbaum, Angela K., Ramsay, R. Eugene, Pennell, Page B., Rarick, John O., Musib, Luna, Leppik, Ilo E., Cloyd, James C.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3973440/
https://ncbi.nlm.nih.gov/pubmed/19299110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eplepsyres.2009.01.013
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki